In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...

Adults with major depressive disorder experienced statistically significant and clinically meaningful improvements with a ...

Vertex makes its largest-ever deal, skyrocketing health insurance costs, and more biotech news from The Readout ...

Years ago, LSD was seen as the evil stepchild of drugs. Today, research indicates LSD may treat anxiety and depression, and ...

About 1 in 5 women will experience depression and anxiety during pregnancy or in the year after giving birth. If untreated, a ...

Helus Pharma™ (NASDAQ: HELP) (Cboe CA: HELP), the commercial operating name of Cybin Inc., says its APPROACH Phase 3 trial of HLP003 for adjunctive treatment of major depressive disorder has surpassed ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE-A lab technician prepares a solution that will be used in a clinical trial. (Photo by Chip Somodevilla/Getty Images) A new ...

DT120, a new LSD-based experimental pill, was used in a clinical trial. Adults between the ages of 18 and 74 with serious depression participated in the trial. Researchers learned that the patients ...

From its headquarters in the heart of New York City, Definium Therapeutics has dropped topline phase 3 data for its psychedelic answer to depression that is almost certain to keep the field’s hype ...

A selective serotonin 4 (5-HT4) receptor agonist approved for chronic constipation improved persistent cognitive symptoms in individuals with remitted major depressive disorder (MDD). Results of the ...

Psychiatrists think inflammation may be at the root of some people’s illness. How to treat it is an open question. By Dana G. Smith Psychiatry has a long history of treating mental illness with drugs ...